Found 15 matching trials
Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population PHASE3 The primary objective is to assess the systemic and local safety profile of...
Show More Location
Research Institute for Tropical Medicine
Learn More & Join Trial
Purified Inactivated Japanese Encephalitis Vaccine PHASE3 This study evaluates the immunogenicity and safety of a purified inactivate...
Show More Location
Disease prevention and control center of Inner Mongolia autonomous region
Learn More & Join Trial
Evalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine in Toddlers PHASE2 This study evaluated the safety and immunogenicity of rabies vaccine and Ja...
Show More Location
Tropical Medicine, Mahidol University
Learn More & Join Trial
Cellular and Humoral Immunity in Elderly After Immunization With a Japanese Encephalitis Vaccine PHASE4 The aim of this project is to investigate humoral and cellular immune respo...
Show More Location
Multiple Locations
Learn More & Join Trial
Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51 PHASE3 The study investigates a rapid immunization regime of the Japanese Encephal...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51 PHASE3 The objective is to demonstrate equivalence of three commercial IC51 batche...
Show More Location
Medizinische Universität Wien, Universitätsklinik für Klinische Pharmakologie
Learn More & Join Trial
Safety and Tolerability of the Japanese Encephalitis Vaccine IC51 PHASE3 The objective is to investigate the safety and tolerability of Japanese Enc...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects. PHASE1 Phase 1 study to evaluate two doses of Alum Adjuvanted Zika Virus Purified ...
Show More Location
Walter Reed Army Institute of Research - Clinical Trials Center
Learn More & Join Trial
Immunogenicity and Safety of the Japanese Encephalitis Vaccine IC51 (IXIARO®, JESPECT®) in a Pediatric Population in Non-endemic Countries PHASE3 The primary objective is to assess the safety profile of IC51 in a pediatri...
Show More Location
Tampa Clinical Research Inc.
Learn More & Join Trial
Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51 N/A The study investigates the long term safety and immunogenicity of the Japan...
Show More Location
Multiple Locations
Learn More & Join Trial